Siton, Ralp Vincent .
HRN: 26-90-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2025
04/13/2025
IV
25mg LD Then 13mg Maintenance
13mg Q24 Hours
Sepsis Neonatorum
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes